Review



rabbit anti human cd55 polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech rabbit anti human cd55 polyclonal antibody
    Expression of <t>CD55</t> mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC
    Rabbit Anti Human Cd55 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+cd55+polyclonal+antibody/CD55+Antibody/pmc12542390-153-2-7
    Average 93 stars, based on 14 article reviews
    rabbit anti human cd55 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study"

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    Journal: World Journal of Surgical Oncology

    doi: 10.1186/s12957-025-04051-2

    Expression of CD55 mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC
    Figure Legend Snippet: Expression of CD55 mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC

    Techniques Used: Expressing

    Intensities of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: low expression ( B , 40×; b, 200×); scored 2: moderate expression ( C , 40×; c, 200×); scored 3: high expression ( D , 40×; d, 200×)
    Figure Legend Snippet: Intensities of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: low expression ( B , 40×; b, 200×); scored 2: moderate expression ( C , 40×; c, 200×); scored 3: high expression ( D , 40×; d, 200×)

    Techniques Used: Expressing

    Proportion of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: 1% − 30% positive cells ( B , 40×; b, 200×); scored 2: 30% − 60% positive cells ( C , 40×; c, 200×); scored 3: ≥ 60% positive cells ( D , 40×; d, 200×)
    Figure Legend Snippet: Proportion of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: 1% − 30% positive cells ( B , 40×; b, 200×); scored 2: 30% − 60% positive cells ( C , 40×; c, 200×); scored 3: ≥ 60% positive cells ( D , 40×; d, 200×)

    Techniques Used: Expressing

    Kaplan-Meier Survival Analysis in TETs The results demonstrated that PFS of TETs was closely related to CD55 mRNA ( A , p < 0.0001), CD55 protein ( B , p < 0.0001), tumor completeness of resection ( C , p < 0.0001), histological type ( D , p < 0.0001), Masaoka-Koga stage ( E , p < 0.0001), and adjuvant therapy ( F , p = 0.0009), but no with gender ( G , p = 0.1805) or MG ( H , p = 0.7269)
    Figure Legend Snippet: Kaplan-Meier Survival Analysis in TETs The results demonstrated that PFS of TETs was closely related to CD55 mRNA ( A , p < 0.0001), CD55 protein ( B , p < 0.0001), tumor completeness of resection ( C , p < 0.0001), histological type ( D , p < 0.0001), Masaoka-Koga stage ( E , p < 0.0001), and adjuvant therapy ( F , p = 0.0009), but no with gender ( G , p = 0.1805) or MG ( H , p = 0.7269)

    Techniques Used: Adjuvant

    The relationship between CD55 and the clinical pathological features of patients The expression levels of CD55 mRNA and protein were higher in R1/R2 group ( A ), higher histological grade ( B ), Masaoka-Koga stage III/IV ( C ), adjuvant therapy ( D ) compared with the corresponding R0 group, normal thymus tissues, and stage I/II, and no-adjuvant therapy. Moreover, the expression of CD55 protein was significantly higher expressed in ≥ 60 years compared with ˂60 years ( E ). Additionally, CD55 protein expression was higher in males than that in females ( F ), whereas CD55 mRNA did not show similar results ( E, F ). Patients without MG showed higher CD55 mRNA and protein expression levels than those with MG, however, this difference was not statistically significant ( G ). There was also no statistically significant relationship between tumor diameter and CD55 expression ( H ). When CD55 protein was highly expressed, the mRNA level was also high ( I ).
    Figure Legend Snippet: The relationship between CD55 and the clinical pathological features of patients The expression levels of CD55 mRNA and protein were higher in R1/R2 group ( A ), higher histological grade ( B ), Masaoka-Koga stage III/IV ( C ), adjuvant therapy ( D ) compared with the corresponding R0 group, normal thymus tissues, and stage I/II, and no-adjuvant therapy. Moreover, the expression of CD55 protein was significantly higher expressed in ≥ 60 years compared with ˂60 years ( E ). Additionally, CD55 protein expression was higher in males than that in females ( F ), whereas CD55 mRNA did not show similar results ( E, F ). Patients without MG showed higher CD55 mRNA and protein expression levels than those with MG, however, this difference was not statistically significant ( G ). There was also no statistically significant relationship between tumor diameter and CD55 expression ( H ). When CD55 protein was highly expressed, the mRNA level was also high ( I ).

    Techniques Used: Expressing, Adjuvant

    Kaplan-Meier Survival Analysis in high-risk TETs The results demonstrated that PFS of high-risk TETs was closely related to high expression of CD55 mRNA (A, p < 0.0001) and CD55 protein (B, p = 0.0168)
    Figure Legend Snippet: Kaplan-Meier Survival Analysis in high-risk TETs The results demonstrated that PFS of high-risk TETs was closely related to high expression of CD55 mRNA (A, p < 0.0001) and CD55 protein (B, p = 0.0168)

    Techniques Used: Expressing

    Related Articles

    Expressing:

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study
    Article Snippet: Subsequently, IHC staining was performed according to the manufacturer’s protocol, including sectioning, deparaffinization with gradient ethanol, dehydration with xylene, antigen retrieval and blocking, incubation with primary and secondary antibodies, DAB chromogenic development, counterstaining, and mounting.Subsequently, IHC staining was performed according to the manufacturer’s protocol, including sectioning, deparaffinization with gradient ethanol, dehydration with xylene, antigen retrieval and blocking, incubation with primary and secondary antibodies, DAB chromogenic development, counterstaining, and mounting.. The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.. All slides were evaluated by three pathologists using a double-blind method according to the score of proportion and intensity of tumor cells with CD55 positivity.All slides were evaluated by three pathologists using a double-blind method according to the score of proportion and intensity of tumor cells with CD55 positivity.

    Adjuvant:

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study
    Article Snippet: Subsequently, IHC staining was performed according to the manufacturer’s protocol, including sectioning, deparaffinization with gradient ethanol, dehydration with xylene, antigen retrieval and blocking, incubation with primary and secondary antibodies, DAB chromogenic development, counterstaining, and mounting.Subsequently, IHC staining was performed according to the manufacturer’s protocol, including sectioning, deparaffinization with gradient ethanol, dehydration with xylene, antigen retrieval and blocking, incubation with primary and secondary antibodies, DAB chromogenic development, counterstaining, and mounting.. The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.. All slides were evaluated by three pathologists using a double-blind method according to the score of proportion and intensity of tumor cells with CD55 positivity.All slides were evaluated by three pathologists using a double-blind method according to the score of proportion and intensity of tumor cells with CD55 positivity.



    Similar Products

    93
    Proteintech rabbit anti human cd55 polyclonal antibody
    Expression of <t>CD55</t> mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC
    Rabbit Anti Human Cd55 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+cd55+polyclonal+antibody/CD55+Antibody/pmc12542390-153-2-7
    Average 93 stars, based on 1 article reviews
    rabbit anti human cd55 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology polyclonal rabbit anti-human cd55 antibody
    Sera from BALB/c mice vaccinated with B5/CpG/alum was used to neutralize EV produced in SVAREC cells expressing CD55 (striped bars), <t>CD59</t> (white bars), or no human regulators of C' (black bars) in the presence of 20% human C'. While a full range of antibody dilutions were tested, shown is a representative low dilution (1/80) and high dilution (1/640) of antibody and the effect on complement-mediated neutralization of EV containing CD55 or CD59. The full range of antibody dilutions revealed that EV was partially protected by CD59 at dilutions between 1/80 and 1/640, but not as protective as CD55 at those dilutions. Data is shown as percent neutralization of no antibody control. Error bars represent standard deviation. * p<0.05.
    Polyclonal Rabbit Anti Human Cd55 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+cd55+polyclonal+antibody/cd34+antibody/pmc03110783-87-22-25
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-human cd55 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit anti-human cd55 polyclonal antibody h319
    Sera from BALB/c mice vaccinated with B5/CpG/alum was used to neutralize EV produced in SVAREC cells expressing CD55 (striped bars), <t>CD59</t> (white bars), or no human regulators of C' (black bars) in the presence of 20% human C'. While a full range of antibody dilutions were tested, shown is a representative low dilution (1/80) and high dilution (1/640) of antibody and the effect on complement-mediated neutralization of EV containing CD55 or CD59. The full range of antibody dilutions revealed that EV was partially protected by CD59 at dilutions between 1/80 and 1/640, but not as protective as CD55 at those dilutions. Data is shown as percent neutralization of no antibody control. Error bars represent standard deviation. * p<0.05.
    Rabbit Anti Human Cd55 Polyclonal Antibody H319, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+cd55+polyclonal+antibody/cd34+antibody/pm19501411-71-23-24
    Average 90 stars, based on 1 article reviews
    rabbit anti-human cd55 polyclonal antibody h319 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Expression of CD55 mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: Expression of CD55 mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Expressing

    Intensities of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: low expression ( B , 40×; b, 200×); scored 2: moderate expression ( C , 40×; c, 200×); scored 3: high expression ( D , 40×; d, 200×)

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: Intensities of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: low expression ( B , 40×; b, 200×); scored 2: moderate expression ( C , 40×; c, 200×); scored 3: high expression ( D , 40×; d, 200×)

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Expressing

    Proportion of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: 1% − 30% positive cells ( B , 40×; b, 200×); scored 2: 30% − 60% positive cells ( C , 40×; c, 200×); scored 3: ≥ 60% positive cells ( D , 40×; d, 200×)

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: Proportion of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: 1% − 30% positive cells ( B , 40×; b, 200×); scored 2: 30% − 60% positive cells ( C , 40×; c, 200×); scored 3: ≥ 60% positive cells ( D , 40×; d, 200×)

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Expressing

    Kaplan-Meier Survival Analysis in TETs The results demonstrated that PFS of TETs was closely related to CD55 mRNA ( A , p < 0.0001), CD55 protein ( B , p < 0.0001), tumor completeness of resection ( C , p < 0.0001), histological type ( D , p < 0.0001), Masaoka-Koga stage ( E , p < 0.0001), and adjuvant therapy ( F , p = 0.0009), but no with gender ( G , p = 0.1805) or MG ( H , p = 0.7269)

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: Kaplan-Meier Survival Analysis in TETs The results demonstrated that PFS of TETs was closely related to CD55 mRNA ( A , p < 0.0001), CD55 protein ( B , p < 0.0001), tumor completeness of resection ( C , p < 0.0001), histological type ( D , p < 0.0001), Masaoka-Koga stage ( E , p < 0.0001), and adjuvant therapy ( F , p = 0.0009), but no with gender ( G , p = 0.1805) or MG ( H , p = 0.7269)

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Adjuvant

    The relationship between CD55 and the clinical pathological features of patients The expression levels of CD55 mRNA and protein were higher in R1/R2 group ( A ), higher histological grade ( B ), Masaoka-Koga stage III/IV ( C ), adjuvant therapy ( D ) compared with the corresponding R0 group, normal thymus tissues, and stage I/II, and no-adjuvant therapy. Moreover, the expression of CD55 protein was significantly higher expressed in ≥ 60 years compared with ˂60 years ( E ). Additionally, CD55 protein expression was higher in males than that in females ( F ), whereas CD55 mRNA did not show similar results ( E, F ). Patients without MG showed higher CD55 mRNA and protein expression levels than those with MG, however, this difference was not statistically significant ( G ). There was also no statistically significant relationship between tumor diameter and CD55 expression ( H ). When CD55 protein was highly expressed, the mRNA level was also high ( I ).

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: The relationship between CD55 and the clinical pathological features of patients The expression levels of CD55 mRNA and protein were higher in R1/R2 group ( A ), higher histological grade ( B ), Masaoka-Koga stage III/IV ( C ), adjuvant therapy ( D ) compared with the corresponding R0 group, normal thymus tissues, and stage I/II, and no-adjuvant therapy. Moreover, the expression of CD55 protein was significantly higher expressed in ≥ 60 years compared with ˂60 years ( E ). Additionally, CD55 protein expression was higher in males than that in females ( F ), whereas CD55 mRNA did not show similar results ( E, F ). Patients without MG showed higher CD55 mRNA and protein expression levels than those with MG, however, this difference was not statistically significant ( G ). There was also no statistically significant relationship between tumor diameter and CD55 expression ( H ). When CD55 protein was highly expressed, the mRNA level was also high ( I ).

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Expressing, Adjuvant

    Kaplan-Meier Survival Analysis in high-risk TETs The results demonstrated that PFS of high-risk TETs was closely related to high expression of CD55 mRNA (A, p < 0.0001) and CD55 protein (B, p = 0.0168)

    Journal: World Journal of Surgical Oncology

    Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

    doi: 10.1186/s12957-025-04051-2

    Figure Lengend Snippet: Kaplan-Meier Survival Analysis in high-risk TETs The results demonstrated that PFS of high-risk TETs was closely related to high expression of CD55 mRNA (A, p < 0.0001) and CD55 protein (B, p = 0.0168)

    Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

    Techniques: Expressing

    Sera from BALB/c mice vaccinated with B5/CpG/alum was used to neutralize EV produced in SVAREC cells expressing CD55 (striped bars), CD59 (white bars), or no human regulators of C' (black bars) in the presence of 20% human C'. While a full range of antibody dilutions were tested, shown is a representative low dilution (1/80) and high dilution (1/640) of antibody and the effect on complement-mediated neutralization of EV containing CD55 or CD59. The full range of antibody dilutions revealed that EV was partially protected by CD59 at dilutions between 1/80 and 1/640, but not as protective as CD55 at those dilutions. Data is shown as percent neutralization of no antibody control. Error bars represent standard deviation. * p<0.05.

    Journal: PLoS ONE

    Article Title: Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors

    doi: 10.1371/journal.pone.0020597

    Figure Lengend Snippet: Sera from BALB/c mice vaccinated with B5/CpG/alum was used to neutralize EV produced in SVAREC cells expressing CD55 (striped bars), CD59 (white bars), or no human regulators of C' (black bars) in the presence of 20% human C'. While a full range of antibody dilutions were tested, shown is a representative low dilution (1/80) and high dilution (1/640) of antibody and the effect on complement-mediated neutralization of EV containing CD55 or CD59. The full range of antibody dilutions revealed that EV was partially protected by CD59 at dilutions between 1/80 and 1/640, but not as protective as CD55 at those dilutions. Data is shown as percent neutralization of no antibody control. Error bars represent standard deviation. * p<0.05.

    Article Snippet: We confirmed expression of human CD55 and human CD59 in these cell lines by western blotting using polyclonal rabbit anti-human CD55 and anti-human CD59 antibodies (Santa Cruz Biotechnology) ( ).

    Techniques: Produced, Expressing, Neutralization, Control, Standard Deviation